中国医药导报
中国医药期刊欢迎您 今天是   2025年4月4日星期五
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  中医中药 本期目录 | 过刊浏览 | 高级检索 |
基于数据挖掘探讨杜雨茂教授治疗慢性肾衰竭的组方用药规律
胡蝶1  冷伟2  田文娜2  杜治锋3
1. 陕西中医药大学第一临床医学院,陕西咸阳   712000;
2.陕西中医药大学附属医院风湿免疫血液科,陕西咸阳   712000;
3.陕西省咸阳雨茂医院陕西杜氏肾病学术流派传承工作室,陕西咸阳   712000
Study on medication rules of Professor Du Yumao in the treatment of chronic renal failure based on data mining
HU Die1 LENG Wei2 TIAN Wenna2 DU Zhifeng3
1.The First Clinical Medical College, Shaanxi University of Chinese Medicine, Shaanxi Province, Xianyang   712000, China; 
2.Department of Rheumatic Immunology and Hematology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Shaanxi Province, Xianyang   712000, China; 
3.Academic School Inheritance Studio of Shaanxi Du’s Kidney Disease, Yumao Hospital, Shaanxi Province, Xianyang   712000, China
全文: PDF (863 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 运用数据挖掘技术探讨杜雨茂教授治疗慢性肾衰竭的组方用药规律。 方法 以咸阳雨茂医院病案为资料来源,收集并整理杜教授于1998年1月至2011年12月所治疗的慢性肾衰竭患者病案,应用中医传承辅助平台(V2.5),统计分析用药频次、性味归经,利用关联规则和聚类算法得出常用药物组合及潜在新方。 结果 共纳入符合研究标准的处方640首,涉及中药214味,用药频次≥40的有59味,发现杜教授治疗慢性肾衰竭主要由补虚药、利水渗湿药、活血化瘀药等组成。其中,补气首选白术,补阳常用淫羊藿,滋阴多用天冬;用药药性以寒、温为主,药味以甘、苦、辛为多,主要归入肝、脾经。通过关联规则分析得到核心药物8味,具体为白术、黄芪、茯苓、丹参、柴胡、炒黄芩、川芎、虎杖;得到2味药关联规则14条,3味药关联规则25条;聚类分析得到潜在新方4个。 结论 本研究分析杜教授治疗慢性肾衰竭的组方用药规律,发现潜在新方,对临床治疗有指导意义。

服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
胡蝶1  冷伟2  田文娜2  杜治锋3
关键词 数据挖掘杜雨茂慢性肾衰竭用药规律    
Abstract:Objective To explore medication rules of Professor Du Yumao in the treatment of chronic renal failure based on data mining technology. Methods The medical records of chronic kidney failure patients treated by Professor Du from January 1998 to December 2011 were collected and organized based on the medical records of Xianyang Yumao Hospital. The traditional Chinese medicine inheritance assistance platform (V2.5) was applied to statistical analysis of medication frequency, sexual taste and meridian distribution. Association rules and clustering algorithms were used to derive commonly used drug combinations and potential new prescriptions. Results A total of 640 prescriptions that met the research criteria were included, involving 214 traditional Chinese medicines. Among them, 59 flavors with medication frequency more than 40 times. It was found that Professor Du in the treatment of chronic renal failure mainly consists of tonifying deficiency drugs, diuretic and dampness absorbing drugs, and blood activating and stasis resolving drugs. Among them, Atractylodis Macrocephalae Rhizoma was the preferred method for tonifying qi, Epimedii Folium was commonly used for tonifying yang, and Asparagi Radix was commonly used for nourishing yin. The medicinal properties of the medicine were mainly cold and warm, and the medicinal flavors were mainly sweet, bitter, and spicy, mainly classified into the liver and spleen meridians. Through association rule analysis, eight core drugs were obtained, including Atractylodis Macrocephalae Rhizoma, Astr- agali Radix, Poria, Salviae Miltiorrhizae Radix Et Rhizoma, Bupleuri Radix, Scutellariae Radix, Chuanxiong Rhizoma, and Polygoni Cuspidati Rhizoma Et Radix. Fourteen association rules for two drugs were obtained, and 25 association rules for three drugs were obtained. Four potential new parties were identified through cluster analysis. Conclusion This study analyzes the medication rules of Professor Du in the treatment of chronic kidney failure and identifies potential new prescriptions, which have guiding significance for clinical treatment.
Key wordsData mining    Du Yumao    Chronic renal failure    Medication rules
    
基金资助:陕西省中医药管理局科研项目(2021-ZZ-JC 008);
陕西省社会科学基金项目(2021GJ004)。
通讯作者: 冷伟(1976.4-),男,博士,副教授,硕士生导师;研究方向:中医内科学的理论与基础研究。   
作者简介: 胡蝶(1995.9-),女,陕西中医药大学第一临床医学院2020级中医内科学专业在读硕士研究生;研究方向:中医肾病的基础与临床研究。
引用本文:   
胡蝶1  冷伟2  田文娜2  杜治锋3. 基于数据挖掘探讨杜雨茂教授治疗慢性肾衰竭的组方用药规律[J]. 中国医药导报, 2023, 20(14): 151-154,187.
HU Die1 LENG Wei2 TIAN Wenna2 DU Zhifeng3. Study on medication rules of Professor Du Yumao in the treatment of chronic renal failure based on data mining. 中国医药导报, 2023, 20(14): 151-154,187.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.14.32     或     https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I14/151

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司